CogNeuro_UFMG

Highlights do @cogneuroufmg no XXXI Congresso Brasileiro de Neurologia em Campinas! Foram dias intensos de aprendizado, atualizações e conexões. Nosso agradecimento especial a todos os colegas que acompanharam nossas apresentações. Nos vemos em 2025 na #RPDA!

Two great conversations this week in Peru: @WorldDementia hosted a symposium on public policy approaches to #ENDALZ in LATAM, and @alzassociation convened the region’s dementia research, care and public health communities for #AAICSatellite.

Our Vice Chair @CaramelliPaulo presents during the "Capacity Building in Latin America" session at #aaicsatellite, offering opportunities for growth such as wider development and adoption of National Dementia Plans and increased invsetment in workforce training and infrastructure

We're pleased to announce @joannepikedrph as our new Chair & @CaramelliPaulo as Vice Chair. “I look forward to working with Drs. Pike & Caramelli as we renew our shared international commitment to ensuring dementia remains a priority on the global policy agenda” -@lennyshallcross

🔬 LatAm FINGERS researchers met in Dominican Republic to advance Alzheimer’s prevention in Latin America! 🌎 With 12 countries & 1,200 participants, we’re tackling dementia through lifestyle interventions. Grateful to the @endalzal & our amazing team! 💡💜

En la reunión de LatAm FINGERS honramos la memoria del gran Dr. Francisco Lopera, investigador, profesor, mentor y ejemplo. Non omnis moriar, magna hereditas manet.

Two days of intense work and interactions in the 5th @LatamFingers investigators meeting in Dominican Republic. Unprecedented initiative in the field of dementia, gathering colleagues from 12 Latin American countries. Local work & local leadership with @alzassociation funding

How many people with dementia live in Brazil? / Quantas pessoas com demência vivem no Brasil? Delphi study/estudo Delphi led by/liderado por @marlon_aliberti and @CleusaFerri. International Journal of Geriatric Psychiatry | Wiley Online Library onlinelibrary.wiley.com/doi/epdf/10.10…

CogNeuro's paper of the week: Alzheimer’s disease at the molecular level🧠 This review explores the physiopathological mechanisms behind AD, emphasizing amyloid plaques, tau tangles, and potential biomarkers for early diagnosis and treatment. ➡️bit.ly/3DfghNR

CogNeuro's paper of the week: How do educational disparities shape brain health across regions? 🌎 This study shows how education influences brain structure and dementia, highlighting differences between Latin America and the United States. ➡️ bit.ly/41tQ6gB

CogNeuro's paper of the week: How can we address gaps in frontotemporal dementia research globally? 🌍 This perspective highlights disparities in FTD studies and calls for more diverse, inclusive, and equitable research efforts worldwide. ➡️ bit.ly/3VFjjkL

CogNeuro's paper of the week: How can biomarkers improve Alzheimer’s diagnosis in Brazil? 🇧🇷 The @abneuro_ provides guidelines for rational use and interpretation, emphasizing clinical diagnosis as a key first step. ➡️ bit.ly/4gdCQRx

CogNeuro's paper of the week: How should Brazil approach anti-amyloid therapies for Alzheimer’s? 🇧🇷 The @abneuro_ 's position paper discusses challenges in diagnosis, safety, cost, and diversity in trials, offering key recommendations. ➡️bit.ly/3ZD6AjI

CogNeuro's paper of the week: How can we improve dementia care in low- and middle-income countries? 🌍 This survey reveals disparities in diagnosis, tools, and resources. A call for action across global stakeholders! ➡️ bit.ly/3VyE7dR

CogNeuro's paper of the week: Alzheimer’s disease criteria adaptation for Latin America: Limited biomarker access and regional disparities challenge implementation, but blood-based biomarkers and regional collaborations may help! ➡️ bit.ly/4g2Viwh

CogNeuro's paper of the week: Can hearing aids improve quality of life in people with dementia and hearing loss? We found that while cognitive outcomes remained unchanged, hearing aids significantly enhanced quality of life. ➡️ bit.ly/4gx9Zay

Join us on Thursday for the first in our Dementia in Latin America and the Caribbean virtual series, focused on advancing dementia research and clinical trials in Latin America and the Caribbean. Learn more: bit.ly/4e3LPUx

🚨 IWG-2024: Cognitively normal individuals with Alzheimer’s biomarkers should be considered at-risk rather than diagnosed with Alzheimer’s. Recommendations include contributions from our PIs, Profs: Paulo Caramelli and Leonardo Cruz, along with a diverse group of investigators.